Ignite Creation Date:
2025-12-24 @ 3:05 PM
Ignite Modification Date:
2026-01-03 @ 5:13 PM
Study NCT ID:
NCT04194359
Status:
UNKNOWN
Last Update Posted:
2023-03-17
First Post:
2019-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-09
First Submit QC Date:
None
Study First Post Date:
2019-12-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-14
Last Update Post Date:
2023-03-17
Last Update Post Date Type:
ACTUAL